![(7α,17β)-3,17-Dihydroxy-7-[9-[(4,4,5,5,5-pentafluoropentyl)thio]nonyl]estra-1,3,5(10)-trien-6-one](https://static.cymitquimica.com/cas-image/394792-7a-17b-317-dihydroxy-7-9-44555-pentafluoropentyl-thio-nonyl-estra-135-10-trien-6-one.png)
CAS: 1107606-70-1 - (7α,17β)-3,17-Dihydroxy-7-[9-[(4,4,5,5,5-pentafluoropentyl)thio]nonyl]estra-1,3,5(10)-trien-6-one
Fórmula:C32H45F5O3S
InChI:InChI=1S/C32H45F5O3S/c1-30-17-15-23-22-12-11-21(38)20-25(22)29(40)24(28(23)26(30)13-14-27(30)39)10-7-5-3-2-4-6-8-18-41-19-9-16-31(33,34)32(35,36)37/h11-12,20,23-24,26-28,38-39H,2-10,13-19H2,1H3/t23-,24+,26+,27+,28+,30+/m1/s1
Clave InChI:InChIKey=MGJKDKSBKCPJCM-GYKPOOFLSA-N
SMILES:O=C1C2=CC(O)=CC=C2C3CCC4(C)C(O)CCC4C3C1CCCCCCCCCSCCCC(F)(F)C(F)(F)F
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | Fulvestrant Impurity 18 REF: 4Z-F-3126CAS: 1107606-70-1 | - - - | A consultar | Jue 17 Oct 24 |
 | S-Deoxo-6-oxo-fulvestrant REF: TR-D231615CAS: 1107606-70-1 | - - - | 244,00 €~1.629,00 € | Mar 26 Nov 24 |
 | S-Deoxo-6-oxo-fulvestrant REF: 3D-HUB60670CAS: 1107606-70-1 | Min. 95% | A consultar | Mié 27 Nov 24 |
Ref: 4Z-F-3126
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Jueves 17 de Octubre de 2024
S-Deoxo-6-oxo-fulvestrant
Producto controladoCAS:1107606-70-1
Applications Fulvestrant (F862500) impurity E derivative. Used in the preparation of steroids precursor with hormonal …
Fórmula:
C32H45F5O3S
Forma y color:
Neat
Peso molecular:
604.75
Ref: TR-D231615
| 25mg | 1.629,00 € | ||
| 2500µg | 244,00 € |
Entrega estimada en Estados Unidos, el Martes 26 de Noviembre de 2024
S-Deoxo-6-oxo-fulvestrant
CAS:1107606-70-1
S-Deoxo-6-oxo-fulvestrant is a potent tumor inhibitor and analog of fulvestrant, which is used to treat …
Fórmula:
C32H45F5O3S
Pureza:
Min. 95%
Peso molecular:
604.8 g/mol
Ref: 3D-HUB60670
| 25mg | A consultar | ||
| 50mg | A consultar |
Entrega estimada en Estados Unidos, el Miércoles 27 de Noviembre de 2024
